nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—SLC7A11—Amino acid transport across the plasma membrane—SLC3A1—nephrolithiasis	0.0522	0.109	CbGpPWpGaD
Riluzole—SLC7A11—Basigin interactions—SLC7A9—nephrolithiasis	0.0389	0.0816	CbGpPWpGaD
Riluzole—SLC7A11—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0362	0.0759	CbGpPWpGaD
Riluzole—SLC7A11—Amino acid transport across the plasma membrane—SLC7A9—nephrolithiasis	0.0328	0.0687	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0233	0.0488	CbGpPWpGaD
Riluzole—SLC7A11—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0227	0.0476	CbGpPWpGaD
Riluzole—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0217	0.0415	CcSEcCtD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0213	0.0447	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0213	0.0447	CbGpPWpGaD
Riluzole—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0338	CcSEcCtD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0161	0.0338	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.015	0.0315	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0134	0.028	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—SLC7A9—nephrolithiasis	0.0129	0.0271	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC2A9—nephrolithiasis	0.0106	0.0223	CbGpPWpGaD
Riluzole—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0203	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0104	0.0218	CbGpPWpGaD
Riluzole—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00978	0.0187	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00952	0.02	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00952	0.02	CbGpPWpGaD
Riluzole—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00913	0.0192	CbGpPWpGaD
Riluzole—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00879	0.0168	CcSEcCtD
Riluzole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00831	0.0159	CcSEcCtD
Riluzole—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0156	CcSEcCtD
Riluzole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0143	CcSEcCtD
Riluzole—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00726	0.0139	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00721	0.0151	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00721	0.0151	CbGpPWpGaD
Riluzole—Gout—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0138	CcSEcCtD
Riluzole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00712	0.0136	CcSEcCtD
Riluzole—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00685	0.0131	CcSEcCtD
Riluzole—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00673	0.0129	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0067	0.0141	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0067	0.0141	CbGpPWpGaD
Riluzole—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00632	0.0121	CcSEcCtD
Riluzole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00609	0.0116	CcSEcCtD
Riluzole—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00599	0.0115	CcSEcCtD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00598	0.0125	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00593	0.0124	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00593	0.0124	CbGpPWpGaD
Riluzole—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0107	CcSEcCtD
Riluzole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00556	0.0106	CcSEcCtD
Riluzole—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0104	CcSEcCtD
Riluzole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00532	0.0102	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00529	0.0111	CbGpPWpGaD
Riluzole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00527	0.0101	CcSEcCtD
Riluzole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00994	CcSEcCtD
Riluzole—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00518	0.0099	CcSEcCtD
Riluzole—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00986	CcSEcCtD
Riluzole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00981	CcSEcCtD
Riluzole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00969	CcSEcCtD
Riluzole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00961	CcSEcCtD
Riluzole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00938	CcSEcCtD
Riluzole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00934	CcSEcCtD
Riluzole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00927	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00484	0.0101	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00484	0.0101	CbGpPWpGaD
Riluzole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00919	CcSEcCtD
Riluzole—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00919	CcSEcCtD
Riluzole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00472	0.00902	CcSEcCtD
Riluzole—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00885	CcSEcCtD
Riluzole—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00878	CcSEcCtD
Riluzole—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00862	CcSEcCtD
Riluzole—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00853	CcSEcCtD
Riluzole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00445	0.0085	CcSEcCtD
Riluzole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00844	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00841	CcSEcCtD
Riluzole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00827	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00824	CcSEcCtD
Riluzole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00824	CcSEcCtD
Riluzole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00813	CcSEcCtD
Riluzole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00807	CcSEcCtD
Riluzole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00807	CcSEcCtD
Riluzole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00791	CcSEcCtD
Riluzole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00786	CcSEcCtD
Riluzole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00755	CcSEcCtD
Riluzole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00755	CcSEcCtD
Riluzole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00746	CcSEcCtD
Riluzole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00743	CcSEcCtD
Riluzole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00737	CcSEcCtD
Riluzole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00384	0.00735	CcSEcCtD
Riluzole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00724	CcSEcCtD
Riluzole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00709	CcSEcCtD
Riluzole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00705	CcSEcCtD
Riluzole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00705	CcSEcCtD
Riluzole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00702	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00366	0.00769	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00366	0.00769	CbGpPWpGaD
Riluzole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00366	0.007	CcSEcCtD
Riluzole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00361	0.0069	CcSEcCtD
Riluzole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00686	CcSEcCtD
Riluzole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00679	CcSEcCtD
Riluzole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00675	CcSEcCtD
Riluzole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00672	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—DGKH—nephrolithiasis	0.00351	0.00736	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—SLC7A9—nephrolithiasis	0.00351	0.00736	CbGpPWpGaD
Riluzole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00658	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00341	0.00715	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00341	0.00715	CbGpPWpGaD
Riluzole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00648	CcSEcCtD
Riluzole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00646	CcSEcCtD
Riluzole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00643	CcSEcCtD
Riluzole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00641	CcSEcCtD
Riluzole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00636	CcSEcCtD
Riluzole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00611	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00304	0.00637	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00304	0.00637	CbGpPWpGaD
Riluzole—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00577	CcSEcCtD
Riluzole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00571	CcSEcCtD
Riluzole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00554	CcSEcCtD
Riluzole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00552	CcSEcCtD
Riluzole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00551	CcSEcCtD
Riluzole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00546	CcSEcCtD
Riluzole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00544	CcSEcCtD
Riluzole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00541	CcSEcCtD
Riluzole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00527	CcSEcCtD
Riluzole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00522	CcSEcCtD
Riluzole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00272	0.0052	CcSEcCtD
Riluzole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00517	CcSEcCtD
Riluzole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00514	CcSEcCtD
Riluzole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00507	CcSEcCtD
Riluzole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00505	CcSEcCtD
Riluzole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00504	CcSEcCtD
Riluzole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00503	CcSEcCtD
Riluzole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00497	CcSEcCtD
Riluzole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00494	CcSEcCtD
Riluzole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00491	CcSEcCtD
Riluzole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00479	CcSEcCtD
Riluzole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00479	CcSEcCtD
Riluzole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00479	CcSEcCtD
Riluzole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00477	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00249	0.00523	CbGpPWpGaD
Riluzole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00473	CcSEcCtD
Riluzole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00468	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00243	0.00509	CbGpPWpGaD
Riluzole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00463	CcSEcCtD
Riluzole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00459	CcSEcCtD
Riluzole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00459	CcSEcCtD
Riluzole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00452	CcSEcCtD
Riluzole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00449	CcSEcCtD
Riluzole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00448	CcSEcCtD
Riluzole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00444	CcSEcCtD
Riluzole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00438	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00229	0.0048	CbGpPWpGaD
Riluzole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00429	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00219	0.00418	CcSEcCtD
Riluzole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00415	CcSEcCtD
Riluzole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00412	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00215	0.00451	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00215	0.00451	CbGpPWpGaD
Riluzole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00409	CcSEcCtD
Riluzole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00408	CcSEcCtD
Riluzole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00404	CcSEcCtD
Riluzole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00399	CcSEcCtD
Riluzole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00396	CcSEcCtD
Riluzole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00393	CcSEcCtD
Riluzole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00393	CcSEcCtD
Riluzole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00378	CcSEcCtD
Riluzole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00375	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00192	0.00402	CbGpPWpGaD
Riluzole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00365	CcSEcCtD
Riluzole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00363	CcSEcCtD
Riluzole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00363	CcSEcCtD
Riluzole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00177	0.00338	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00175	0.00367	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00175	0.00367	CbGpPWpGaD
Riluzole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00329	CcSEcCtD
Riluzole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00325	CcSEcCtD
Riluzole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00314	CcSEcCtD
Riluzole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00304	CcSEcCtD
Riluzole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00292	CcSEcCtD
Riluzole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00289	CcSEcCtD
Riluzole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00289	CcSEcCtD
Riluzole—Headache—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00288	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00146	0.00306	CbGpPWpGaD
Riluzole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00273	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00133	0.00278	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00133	0.00278	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00123	0.00259	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00123	0.00259	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0011	0.00231	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0011	0.00231	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000879	0.00184	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000763	0.0016	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AGXT—nephrolithiasis	0.00068	0.00143	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000578	0.00121	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APRT—nephrolithiasis	0.000578	0.00121	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000516	0.00108	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.00046	0.000965	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000412	0.000864	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000391	0.000821	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000391	0.000821	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000372	0.000781	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000329	0.00069	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000293	0.000615	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000279	0.000585	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.000252	0.000529	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000249	0.000523	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000249	0.000523	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000178	0.000373	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000161	0.000337	CbGpPWpGaD
